Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 59INDUSTRY 51NIH 14NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 38Sarcoma 7CNS 6Endocrine 5Gynecologic 4Gastrointestinal 4Head & Neck 2Dermatologic 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Breast Neoplasms 265Breast Neoplasms, Male 20Breast Carcinoma In Situ 15Carcinoma, Non-Small-Cell Lung 13Prostatic Neoplasms 12Carcinoma, Intraductal, Noninfiltrating 12Neoplasm Metastasis 11Lung Neoplasms 11Carcinoma, Ductal, Breast 11Pain 9Colorectal Neoplasms 9Colonic Neoplasms 9Neoplasms 8Inflammatory Breast Neoplasms 8Osteoporosis 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Ovarian Neoplasms 6Fatigue 6Small Cell Lung Carcinoma 5Rectal Neoplasms 5Testicular Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sezary Syndrome 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Mycosis Fungoides 4Multiple Myeloma 4Melanoma 4Lymphoma, T-Cell, Cutaneous 4

Interventions

Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Kidney Neoplasms × Breast × Clear all
NCT00471432 2023-08-04

OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors

Canadian Cancer Trials Group

Phase 1 Completed
40 enrolled
BreastGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡